Literature DB >> 30910610

Matrix metalloproteinases in keratoconus - Too much of a good thing?

Erica di Martino1, Manir Ali2, Chris F Inglehearn3.   

Abstract

Keratoconus (KC) is a progressive, early onset, and often bilateral eye condition, in which the cornea gradually weakens and bulges out, and in advanced cases may eventually become cone-shaped. The available evidence suggests that it is a multifactorial disease with environmental and genetic contributions. Matrix Metalloproteinases (MMPs) are a family of 24 zinc-dependent proteases with the ability to degrade collagen and other extracellular matrix (ECM) proteins, which are important components of the cornea. During the past two decades a growing body of literature has accumulated suggesting a link between MMPs and keratoconus. This article aims to summarize the current knowledge on the role of MMPs in the pathogenesis of KC. MMP-driven ECM remodelling is thought to be a necessary step for cornea healing, but a fine balance in the expression of MMPs is essential in maintaining the integrity and transparency of the cornea and for its correct healing, and an imbalance in this tightly regulated process may, in the long term, result in the progressive weakening of the cornea. There is extensive evidence that MMPs are upregulated in the corneal tissue and tears of KC patients, implicating dysregulated proteolysis in KC, with an increase in the level of some MMPs, particularly MMP-1 and MMP-9, confirmed in multiple independent studies. There is also evidence for a causative link between inflammation, which could result from the mechanical trauma due to contact lens wearing or/and eye rubbing, and the increased MMPs production observed in KC. However, the precise role of each MMP in the cornea is still unclear and the mechanisms causing their upregulation are mostly undiscovered. Further studies are required to verify the functional role of specific MMPs in KC development and assess the genetic association between common MMPs variants and risk of KC. As MMPs inhibitors are in development, this information could potentially drive the discovery of new treatments for KC.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cornea; Extracellular matrix; Keratoconus; MMPs; Matrix metalloproteases

Mesh:

Substances:

Year:  2019        PMID: 30910610     DOI: 10.1016/j.exer.2019.03.016

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  15 in total

Review 1.  [Histological changes in keratoconus and wound healing after corneal cross-linking].

Authors:  Louisa M Bulirsch; Constance Weber; Marlene Saßmannshausen; Markus Kohlhaas; Frank G Holz; Karin U Loeffler; Martina C Herwig-Carl
Journal:  Ophthalmologe       Date:  2021-12-07       Impact factor: 1.059

2.  Influence of interleukin 17 A and 17 F polymorphisms in keratoconus.

Authors:  Isabela Bronchtein Gomes; Christiane Maria Ayo; Alessandro Garcia Lopes; Laurie Sayuri Kumano; Geraldo Magela de Faria Junior; Gildásio Castello de Almeida; Lilian Castiglioni; Luiz Carlos de Mattos; Cinara Cássia Brandão
Journal:  Mol Biol Rep       Date:  2021-09-23       Impact factor: 2.316

3.  Choroidal thickness assessment in keratoconus patients treated with cross-linking compared to healthy population.

Authors:  Antonio Ballesteros-Sánchez; Concepción De-Hita-Cantalejo; María Carmen Sánchez-González; María-José Bautista-Llamas; José-María Sánchez-González; Beatriz Gargallo-Martínez
Journal:  Int Ophthalmol       Date:  2022-09-23       Impact factor: 2.029

4.  Absence of the c.169+50delTAAACAG mutation of SOD1 gene in a sample of keratoconus patients in Brazilian population.

Authors:  Alessandro Garcia Lopes; Gildásio Castello de Almeida Júnior; Ronan Marques Teixeira; Luiz Carlos de Mattos; Cinara Cássia Brandão de Mattos; Lilian Castiglioni
Journal:  BMC Res Notes       Date:  2020-07-09

Review 5.  Mechanisms of Collagen Crosslinking in Diabetes and Keratoconus.

Authors:  Tina B McKay; Shrestha Priyadarsini; Dimitrios Karamichos
Journal:  Cells       Date:  2019-10-11       Impact factor: 6.600

6.  PPIP5K2 and PCSK1 are Candidate Genetic Contributors to Familial Keratoconus.

Authors:  Mariam Lofty Khaled; Yelena Bykhovskaya; Chunfang Gu; Alice Liu; Michelle D Drewry; Zhong Chen; Barbara A Mysona; Emily Parker; Ryan P McNabb; Hongfang Yu; Xiaowen Lu; Jing Wang; Xiaohui Li; Abdulrahman Al-Muammar; Jerome I Rotter; Louise F Porter; Amy Estes; Mitchell A Watsky; Sylvia B Smith; Hongyan Xu; Khaled K Abu-Amero; Anthony Kuo; Stephen B Shears; Yaron S Rabinowitz; Yutao Liu
Journal:  Sci Rep       Date:  2019-12-18       Impact factor: 4.379

7.  The Role of Atopy in the Choroidal Profile of Keratoconus Patients.

Authors:  Ana Filipa Moleiro; Ana Francisca Aires; Hélio Alves; João Viana Pinto; Ângela Carneiro; Fernando Falcão-Reis; Luís Figueira; João Pinheiro-Costa
Journal:  Clin Ophthalmol       Date:  2021-04-28

8.  Dysregulation of Receptor for Advanced Glycation End Products (RAGE) Expression as a Biomarker of Keratoconus.

Authors:  Valentin Navel; Jean Malecaze; Corinne Belville; Héléna Choltus; Fanny Henrioux; Frédéric Dutheil; François Malecaze; Frédéric Chiambaretta; Loïc Blanchon; Vincent Sapin
Journal:  Dis Markers       Date:  2022-01-15       Impact factor: 3.434

9.  SP1-mediated lncRNA PVT1 modulates the proliferation and apoptosis of lens epithelial cells in diabetic cataract via miR-214-3p/MMP2 axis.

Authors:  Jun Yang; Shaozhen Zhao; Fang Tian
Journal:  J Cell Mol Med       Date:  2019-11-21       Impact factor: 5.310

10.  Increased choroidal thickness is not a disease progression marker in keratoconus.

Authors:  João Pinheiro-Costa; Paulo Jorge Correia; João Viana Pinto; Hélio Alves; Luís Torrão; Raul Moreira; Manuel Falcão; Ângela Carneiro; Maria Dulce Madeira; Fernando Falcão-Reis
Journal:  Sci Rep       Date:  2020-11-17       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.